Wireless receiving circuit and wireless control device

    公开(公告)号:US10993305B2

    公开(公告)日:2021-04-27

    申请号:US16722070

    申请日:2019-12-20

    申请人: Yan Wang

    发明人: Yan Wang

    IPC分类号: H05B47/19 H04W4/00 H04W4/80

    摘要: A wireless receiving circuit and a wireless control device. The wireless receiving circuit includes a signal receiving module, a Bluetooth signal processing module, a voltage stabilization module, and an output control module. An output end of the signal receiving module is connected with an input end of the Bluetooth signal processing module, and a voltage end of the Bluetooth signal processing module is connected with an output end of the voltage stabilization module. An output end of the Bluetooth signal processing module is connected with an input end of the output control module. The signal receiving module is to receive an external Bluetooth signal and is to transmit the signal to the Bluetooth signal processing module. The Bluetooth signal processing module is to process the external Bluetooth signal and is to transmit a control signal to the output control module.

    Method for Detecting multiple DNA Mutations and Copy Number Variations

    公开(公告)号:US20200277654A1

    公开(公告)日:2020-09-03

    申请号:US16875381

    申请日:2020-05-15

    申请人: Yan Wang

    发明人: Yan Wang

    摘要: Disclosed are methods for detecting DNA mutations of target genes in a DNA sample by combining single-molecule clonal amplification and mutant primer specific extension detection. In the method, thousands and millions of DNA molecules are locally amplified to form immobilized DNA clusters of identical sequences. Mutation specific primers are used to anneal to the mutant sequences in the DNA clusters and are extended by DNA polymerase to make labeled DNA strands. The labeled DNA clusters are detected to identify the DNA clusters of mutant sequences. This method enables detection of single mutation molecule and direct enumeration of mutation molecules in the sample. Once generated from a DNA sample, the immobilized DNA clusters can be reused many times for detection of different mutations or sequences of interest. Methods for determining differential gene expression and chromosome copy number variation are also disclosed.

    Method for uses of proinsulin transferrin fusion proteins as prodrugs

    公开(公告)号:US10513563B2

    公开(公告)日:2019-12-24

    申请号:US13476812

    申请日:2012-05-21

    摘要: The present invention provides compositions useful as prodrugs and methods for making the same. The compositions include a fusion protein having a first delivery domain and a second protein precursor domain linked together via a linker sequence. The delivery domain is a protein capable of facilitating entry to a target cells via the endocytotic pathway, such as transferrin. The protein precursor is a prohormone or a profactor, such as proinsulin. Methods of this invention include the steps of selecting a protein suitable as the delivery domain, constructing a vector to encode the fusion protein, and expressing the fusion protein in a suitable expression host. Also disclosed is a method for targeted-delivery of prodrugs to livers and a method of reducing hepatic glucose production.

    Cactus float
    14.
    外观设计

    公开(公告)号:USD849167S1

    公开(公告)日:2019-05-21

    申请号:US29593710

    申请日:2017-02-10

    申请人: Yan Wang

    设计人: Yan Wang

    Disposable array-type micro injection needle head and prefilled syringe

    公开(公告)号:US10058691B2

    公开(公告)日:2018-08-28

    申请号:US14352987

    申请日:2012-08-07

    申请人: Ruifeng Yue Yan Wang

    发明人: Ruifeng Yue Yan Wang

    摘要: The invention discloses a disposable array-type micro injection needle head which comprises a lower needle seat which is configured as a cylindrical column opening at one end and having a top cap at the other end and which is configured to be connected with an injection reservoir; an upper needle seat which is located above the top cap of the lower needle seat with a cavity formed between the upper needle seat and the top cap; a through-hole formed in the top cap which is configured for communicating the cylindrical column with the cavity, wherein a pipetting needle is mounted in the through-hole which has one end communicated with the cavity and the other end located in the cylindrical column and which is configured for extracting injection from the injection reservoir into the cavity; and at least two needle tubes mounted in the upper needle seat, each of which has one end comprising a needle tip for puncturing and for injecting the injection and the other end for mounting on the upper needle seat and for communicating with the cavity. The needle head can be used directly on existing insulin pen, or the cylindrical column can be provided inside it with an injection reservoir to form a disposable prefilled syringe. By using a plurality of thin, short needle tubes for injecting simultaneously, vertical hypodermic injection of medicines such as insulin can be preformed rapidly, leakproof, painlessly, safely and conveniently at various sites of a human body, without needing to pinch skin, while a potential trouble that the medicines be injected into muscles can be avoided. Patient adherence to the treatment regimen and the treatment effect are improved.

    STIMULI RESPONSIVE COMPOSITIONS FOR IRON CHELATION
    17.
    发明申请
    STIMULI RESPONSIVE COMPOSITIONS FOR IRON CHELATION 有权
    用于钢铁焊接的刺激性反应组合物

    公开(公告)号:US20160184344A1

    公开(公告)日:2016-06-30

    申请号:US14876740

    申请日:2015-10-06

    摘要: The present technology provides new compositions comprising at least one cross-linked co-polymer. In some embodiments, the polyacrylamide co-polymer comprises water soluble subunits, cross-linking subunits, and iron chelating subunits. In other embodiments, the co-polymer comprises water soluble units, cross-linking subunits, and substituted subunits, which can be conjugated with iron-chelating agents. When these new particles are exposed to certain environments, such the presence of strong acids or oxidation agents, these particles are capable of breaking up so that the iron chelating agents can chelate iron or other metals from their environments. Methods to prepare these new compositions are also provided. These compositions or compositions comprising nanogels of the present technology may be used to treat metal overload conditions such as iron overload resulting from chronic transfusions.

    摘要翻译: 本技术提供了包含至少一种交联共聚物的新组合物。 在一些实施方案中,聚丙烯酰胺共聚物包含水溶性亚基,交联亚基和铁螯合亚基。 在其它实施方案中,共聚物包含可与铁螯合剂缀合的水溶性单元,交联亚单元和取代亚单元。 当这些新的颗粒暴露于某些环境,如强酸或氧化剂的存在时,这些颗粒能够分解,使得铁螯合剂可以从其环境中螯合铁或其它金属。 还提供了制备这些新组合物的方法。 包含本技术的纳米凝胶的这些组合物或组合物可用于治疗由慢性输血引起的金属过载状况,例如铁超载。

    Methods of making di-tagged DNA libraries from DNA or RNA using double-tagged oligonucleotides
    18.
    发明授权
    Methods of making di-tagged DNA libraries from DNA or RNA using double-tagged oligonucleotides 有权
    使用双标记寡核苷酸从DNA或RNA制备二标记DNA文库的方法

    公开(公告)号:US09243242B2

    公开(公告)日:2016-01-26

    申请号:US14226321

    申请日:2014-03-26

    申请人: Yan Wang

    发明人: Yan Wang

    摘要: Disclosed are methods, compositions and kits related to making double-tagged DNA libraries from RNA/DNA samples. A double-tagged oligonucleotide (DTO) is employed to efficiently add two different tags to ends of DNAs to make a double-tagged DNA libraries. Also disclosed are methods to make mate pair libraries using the double-tagged oligonucleotide, and methods to make double-tagged single stranded DNA. The double-tagged DNA libraries of the invention are ready to be used on next generation sequencing machines.

    摘要翻译: 公开了与从RNA / DNA样品制备双标记DNA文库相关的方法,组合物和试剂盒。 使用双重标记的寡核苷酸(DTO)来有效地将两个不同的标签添加到DNA的末端以制备双标记的DNA文库。 还公开了使用双标记寡核苷酸制备配对文库的方法,以及制备双标记单链DNA的方法。 本发明的双标记DNA文库可以在下一代测序机上使用。

    IGFBP2 Biomarker
    20.
    发明申请
    IGFBP2 Biomarker 审中-公开
    IGFBP2生物标志物

    公开(公告)号:US20150168424A1

    公开(公告)日:2015-06-18

    申请号:US14556402

    申请日:2014-12-01

    申请人: Yan Wang

    发明人: Yan Wang

    摘要: The present invention provides method for quickly and conveniently determining if a given treatment regimen of IGF1R inhibitor is sufficient, e.g., to saturate IGF1R receptors in the body of a subject. Several clinically relevant determinations may be made based on this point, including, for example, whether the dosage of the regimen is sufficient or should be increased.

    摘要翻译: 本发明提供了用于快速和方便地确定给定的IGF1R抑制剂治疗方案是否足够的方法,例如饱和受试者体内的IGF1R受体。 可以基于这一点进行若干临床相关的测定,包括例如方案的剂量是否足够或应当增加。